Baidu
map

Malignant mesothelioma: Advances in immune checkpoint inhibitor and mesothelin-targeted therapies

Hu, ZSI; Ghafoor, A; Sengupta, M; Hassan, R

Hassan, R (corresponding author), NCI, Thorac & GI Malignancies Branch, Ctr Canc Res, NIH, 10 Ctr Dr,10 CCR,Room 4E-5330, Bethesda, MD 20892 USA.

CANCER, ; ():

Abstract

Malignant mesothelioma is an aggressive cancer with a poor prognosis and limited treatment options. For many years, the only US Food and Drug Administ......

Full Text Link


Baidu
map
Baidu
map
Baidu
map